Clinical Study
Analysis of a Standardized Technique for Laparoscopic Cuff Closure following 1924 Total Laparoscopic Hysterectomies
Table 1
Demographics of all 1924 patients in study.
| | Feature | Mean | Range |
| | Age (years) | 52 | (15–97) | | BMI (Kg/m2) | 29 | (14–74) | | Parity (#) | 1 | (0–9) | | Duration of surgery (minutes) | 121 | (24–556) | | Uterine weight (Kg) | 216 | (14–3131) | | Pelvic nodes (#) | 23 | (0–61) | | Inframesenteric nodes (#) | 7 | (0–38) | | Infrarenal nodes (#) | 7 | (0–37) | | Transfusions (#PRBC) | 0 | (0–5) | | Hospital stay (days) | 1 | (1–13) |
| | Preoperative diagnosis | | (%) |
| | Pelvic mass | 415 | 21.6% | | Leiomyoma | 400 | 20.8% | | Endometrial carcinoma | 355 | 18.5% | | Pelvic pain | 126 | 6.5% | | BrCa+/family history | 108 | 5.6% | | Endometrial hyperplasia | 100 | 5.2% | | Transgender | 94 | 4.9% | | Adenomyosis | 86 | 4.5% | | Prolapse | 68 | 3.5% | | Cervical carcinoma | 49 | 2.5% | | Ovarian/tubal carcinoma | 35 | 1.8% | | Cervical dysplasia | 31 | 1.6% | | Menorrhagia | 25 | 1.3% | | Stress incontinence | 15 | 0.8% | | Uterine stromal/other | 13 | 0.7% | | Menstrual migraines/PCOS | 3 | 0.2% | | PID | 1 | 0.1% |
| | Procedure | | % |
| | TLH-BSO | 1723 | 90% | | Appendectomy | 1103 | 57% | | Any lymphadenectomy | 205 | 11% | | McCall’s colposuspension | 149 | 8% | | Adhesiolysis | 134 | 7% | | Endometriosis resection | 83 | 4% | | Burch | 77 | 4% | | RLH-BSO | 76 | 4% | | TLH | 68 | 4% | | TLH-BS | 48 | 3% | | TOT | 26 | 1% | | Ureterolysis | 21 | 1% | | Herniorrhaphy | 13 | 1% | | Posterior repair | 11 | 1% | | Minilaparotomy | 7 | 0% | | Cholecystectomy | 6 | 0% | | Converted | 5 | 0% | | Tumor debulking | 5 | 0% | | RLH-BS | 4 | 0% | | Converted | 3 | 0% | | Episiotomy | 2 | 0% |
| | Postoperative diagnosis | | % |
| | Leiomyoma | 615 | 32.0% | | Endometrial carcinoma | 368 | 19.1% | | Benign ovarian neoplasia | 363 | 18.9% | | Adenomyosis | 174 | 9.0% | | Endometriosis | 127 | 6.6% | | Ovarian/tubal carcinoma | 98 | 5.1% | | Endometrial hyperplasia | 71 | 3.7% | | Cervical carcinoma | 49 | 2.5% | | Cervical dysplasia | 26 | 1.4% | | Adhesions | 15 | 0.8% | | Uterine stromal/other | 9 | 0.5% | | Metastatic cancer | 7 | 0.4% | | PID | 2 | 0.1% |
|
|
